1/17/2013

Protein Sciences has received FDA approval for its new flu vaccine, called Flublok, for patients aged 18 to 49. The vaccine, which is made using an insect virus expression system and genetic technology "offers the potential for faster start-up of the vaccine manufacturing process in the event of a pandemic, because it is not dependent on an egg supply or on availability of the influenza virus," according to an FDA official.

Full Story:
HealthDay News

Related Summaries